01 October 2008 By:
Fedra Pavlou
|
Red wavelength should not be forgotten, Professor Michael Stur advises.

01 October 2008 By:
K. John Morrow, Jr.
|
John Morrow discusses the potential applications of stem cell therapy in retina disease treatment

01 July 2008 By:
John M. Nolan, BSc, PhD
|
Dr John Nolan discusses the crucial role of the macular carotenoids in the prevention of this blinding disease.

25 June 2008 By:
Nancy Groves
|
Fundus autofluorescence imaging, one of the modes available in a new instrument (Spectralis HRA+OCT, Heidelberg Engineering), enhances its utility as a diagnostic device and a tool for monitoring therapy of patients with retinal and macular diseases.

18 June 2008 By:
Lynda Charters
|
The Verteporfin Intravitreal Triamcinolone Acetonide Study (VERITAS) of intravitreal triamcinolone acetonide (Kenalog, Bristol-Myers Squibb) or pegaptanib (Macugen, Pfizer) in combination with photodynamic therapy (PDT) with verteporfin (Visudyne, Novartis Pharmaceuticals) was underpowered to reach definitive conclusions about the therapies.

01 May 2008 By:
Marianne Shahsuvaryan
|
At present, there is no effective early-stage treatment for AMD or for arresting its progression in the early phases.

01 May 2008 By:
Fedra Pavlou
|
New treatments have not only caused major shifts in practice patterns but have also presented feasible options for pathologies other than those for which they were initially developed.

01 May 2008 By:
April Y. Maa, MD, Nalini K. Aggarwal, MD
|
The authors undertook a study based on their own patient records to elucidate whether Avastin does have a viable role to play in the treatment of neovascular glaucoma associated with retinal ischaemic disease.

01 May 2008 By:
Fedra Pavlou
|
Providing patients with renewed hope and the chance of halting and maybe even reversing vision loss, the launch of this anti-VEGF therapy has signalled a permanent change in the way this debilitating disorder is treated worldwide.
